Eric L. Greidinger, M.D.
- American Board of Internal Medicine
- American Board of Internal Med-Rheumatology
- Rheumatology-Internal Medicine
- Internal Medicine
- Chief, Division of Rheumatology
Mixed Connective Tissue Disease
Systemic lupus erythematosis
Programmed cell death
Pathogenesis of disease in scleroderma
SLE and mixed connective tissue disease.
Stanley J. Glaser Research Award
Wolstenholm Memorial Fellow, Arthritis National Research Foundation
Einbender Memorial Lectureship in Lupus Research
John Hopkins University
University of Michigan
University of Michigan
- CD4+ T Cells Target Epitopes Residing within the RNA-Binding Domain of the U1-70-kDa Small Nuclear Ribonucleoprotein Autoantigen and Have Restricted TCR Diversity in an HLA-DR4-Transgenic Murine Model of Mixed Connective Tissue Disease.
- Clinical and immunologic manifestations of mixed connective tissue disease in a Miami population compared to a Midwestern US Caucasian population.
- Immune effects of autoantigen-associated RNA.
- Serological and clinical characterization of anti-dsDNA and anti-PM/Scl double-positive patients.
Chief of the Division of Rheumatology Eric L. Greidinger, M.D. is an expert in Mixed Connective Tissue Disease and related rheumatic overlap syndromes. Continuously funded by federal peer reviewed grants for over 14 years, Dr. Greidinger's research interests include the tissue targeting of autoimmunity and the pathobiology of Raynaud's Phenomenon.
At UM, Dr. Greidinger has made major discoveries regarding the roles of the innate immune system in the pathogenesis of lupus and related conditions, and has developed major new animal models of Mixed Connective Tissue Disease and Raynaud's Phenomenon. As Division Chief, Dr. Greidinger has pioneered the development of the Rheumatology Intake Clinics to speed access to rheumatology services to new patients, grown subspecialty programs in the rheumatic diseases that leverage the world/renowned expertise of our rheumatology faculty, and overseen a quadrupling of the number of funded research studies ongoing by rheumatology faculty.
Dr. Greidinger is a member of the Cancer Center at UM. He serves on the Research and Development and Scientific Review Committees at the Miami VA Medical Center. He serves on numerous scientific review panels, Including for the NIH, VA, Arthritis Foundation, and Lupus Research Institute.
Dr. Greidinger is board-certified in Rheumatology and Internal Medicine.